{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:46:53Z","timestamp":1790477213053,"version":"4.1.0"},"reference-count":79,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1723,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1471-4159.2010.07123.x","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T16:57:32Z","timestamp":1290617852000},"page":"426-437","source":"Crossref","is-referenced-by-count":32,"title":["Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson\u2019s disease"],"prefix":"10.1111","volume":"116","author":[{"given":"Donald M.","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L. Eskow","family":"Jaunarajs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,13]]},"reference":[{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/jnnp.2008.166959","article-title":"The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson\u2019s disease","volume":"80","author":"Aarsland","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000296942.14309.4a","article-title":"Beating a dead horse: dopamine and Parkinson disease","volume":"69","author":"Ahlskog","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1192\/bjp.174.4.307","article-title":"Review of community prevalence of depression in later life","volume":"174","author":"Beekman","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"41352","DOI":"10.1074\/jbc.M403827200","article-title":"Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis","volume":"279","author":"Brennan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1073\/pnas.87.5.1922","article-title":"Serotonin uptake, storage, and synthesis in an immortalized committed cell line derived from mouse teratocarcinoma","volume":"87","author":"Buc-Caron","year":"1990","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(90)90342-9","article-title":"Evidence for decreased transport of tryptophan hydroxylase in Alzheimer\u2019s disease","volume":"537","author":"Burke","year":"1990","journal-title":"Brain Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"28105","DOI":"10.1074\/jbc.M602817200","article-title":"Functional domains of human tryptophan hydroxylase 2 (hTPH2)","volume":"281","author":"Carkaci-Salli","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"issue":"Suppl 2","key":"10.1111\/j.1471-4159.2010.07123.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.parkreldis.2008.04.021","article-title":"Involvement of the serotonin system in L-dopa-induced dyskinesias","volume":"14","author":"Carta","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0166-2236(00)01998-6","article-title":"The role of the ubiquitin-proteasomal pathway in Parkinson\u2019s disease and other neurodegenerative disorders","volume":"24","author":"Chung","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1176\/appi.ajp.159.11.1862","article-title":"Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample","volume":"159","author":"Chwastiak","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1074\/jbc.M705657200","article-title":"Cysteine 111 affects aggregation and cytotoxicity of mutant Cu, Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis","volume":"283","author":"Cozzolino","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1096\/fj.05-4195fje","article-title":"Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer\u2019s disease","volume":"19","author":"Cumming","year":"2005","journal-title":"FASEB J."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"21749","DOI":"10.1074\/jbc.M312267200","article-title":"Protein disulfide bond formation in the cytoplasm during oxidative stress","volume":"279","author":"Cumming","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB22|cit22","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of L-DOPA treatment","author":"Eskow Jaunarajs","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease","volume":"510","author":"Halliday","year":"1990a","journal-title":"Brain Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease","volume":"27","author":"Halliday","year":"1990b","journal-title":"Ann. Neurol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","article-title":"Pathogenesis of familial Parkinson\u2019s disease: new insights based on monogenic forms of Parkinson\u2019s disease","volume":"111","author":"Hatano","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0076-6879(93)17067-F","article-title":"Gene splicing by overlap extension","volume":"217","author":"Horton","year":"1993","journal-title":"Methods Enzymol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6360-3_1","article-title":"Post mortem studies in Parkinson\u2019s disease-is it possible to detect brain areas for specific symptoms?","volume":"56","author":"Jellinger","year":"1999","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.72.9.3575","article-title":"Brain tryptophan hydroxylase: purification of, production of antibodies to, and cellular and ultrastructural localization in serotonergic neurons of rat midbrain","volume":"72","author":"Joh","year":"1975","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1471-4159.1995.65020882.x","article-title":"Tryptophan hydroxylase is phosphorylated by protein kinase A","volume":"65","author":"Johansen","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1471-4159.1996.66020817.x","article-title":"Phosphorylation and activation of tryptophan hydroxylase by exogenous protein kinase A","volume":"66","author":"Johansen","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB34|cit34","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0076-6879(95)51116-4","article-title":"Diamide: an oxidant probe for thiols","volume":"251","author":"Kosower","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00314109","article-title":"Depression and Parkinson\u2019s disease: possible role of serotonergic mechanisms","volume":"234","author":"Kostic","year":"1987","journal-title":"J. Neurol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-200301200-00014","article-title":"Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders","volume":"14","author":"Kovacs","year":"2003","journal-title":"Neuroreport"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1471-4159.1996.67031072.x","article-title":"Inactivation of brain tryptophan hydroxylase by nitric oxide","volume":"67","author":"Kuhn","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1523\/JNEUROSCI.17-19-07245.1997","article-title":"Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center","volume":"17","author":"Kuhn","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.18-18-07111.1998","article-title":"Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons","volume":"18","author":"Kuhn","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(99)00238-7","article-title":"L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein","volume":"73","author":"Kuhn","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"29726","DOI":"10.1074\/jbc.274.42.29726","article-title":"Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity","volume":"274","author":"Kuhn","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/S0021-9258(19)85644-2","article-title":"Tryptophan hydroxylase. The role of oxygen, iron, and sulfhydryl groups as determinants of stability and catalytic activity","volume":"255","author":"Kuhn","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1074\/jbc.M200290200","article-title":"Peroxynitrite-induced nitration of tyrosine hydroxylase: identification of tyrosines 423, 428, and 432 as sites of modification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tyrosine-scanning mutagenesis","volume":"277","author":"Kuhn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04855.x","article-title":"Phosphorylation and activation of tryptophan hydroxylase 2: identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II","volume":"103","author":"Kuhn","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"48976","DOI":"10.1074\/jbc.M208192200","article-title":"Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01250960","article-title":"The mechanism of perturbation in monoamine metabolism by L-dopa therapy: in vivo and in vitro studies","volume":"90","author":"Maruyama","year":"1992","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with parkinson\u2019s disease","volume":"34","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","article-title":"A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson\u2019s disease patients without dementia","volume":"14","author":"McKinlay","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0167-4838(97)00069-1","article-title":"Carboxyl terminal deletion analysis of tryptophan hydroxylase. Biochim","volume":"1342","author":"Mockus","year":"1997","journal-title":"Biophys. Acta"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/jnp.13.2.222","article-title":"In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"13","author":"Murai","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1523\/JNEUROSCI.5031-09.2010","article-title":"High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson\u2019s disease","volume":"30","author":"Navailles","year":"2010a","journal-title":"J. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson\u2019s disease","volume":"38","author":"Navailles","year":"2010b","journal-title":"Neurobiol. Dis."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1034\/j.1600-0447.2001.00372.x","article-title":"Increased risk of developing Parkinson\u2019s disease for patients with major affective disorder: a register study","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"28087","DOI":"10.1074\/jbc.M704465200","article-title":"Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1","volume":"282","author":"Niwa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson\u2019s disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/24.7.8567","article-title":"Monoamine-synthesizing enzymes in central dopaminergic, noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron microscopy","volume":"24","author":"Pickel","year":"1976","journal-title":"J. Histochem. Cytochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1471-4159.2007.04741.x","article-title":"Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism","volume":"103","author":"Ren","year":"2007","journal-title":"J. Neurochem."},{"issue":"Suppl 1","key":"10.1111\/j.1471-4159.2010.07123.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-4159.2005.03604.x","article-title":"Mouse tryptophan hydroxylase isoform 2 and the role of proline 447 in enzyme function","volume":"96","author":"Sakowski","year":"2006a","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2006.02.047","article-title":"Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies","volume":"1085","author":"Sakowski","year":"2006b","journal-title":"Brain Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01260420","article-title":"Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients","volume":"62","author":"Sawada","year":"1985","journal-title":"J. Neural Transm."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"13771","DOI":"10.1074\/jbc.M707494200","article-title":"Aberrant folding of pathogenic parkin mutants: aggregation versus degradation","volume":"283","author":"Schlehe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2006.05.030","article-title":"Quality of life and depression in Parkinson\u2019s disease","volume":"248","author":"Schrag","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","article-title":"Increased risk of Parkinson\u2019s disease after depression: a retrospective cohort study","volume":"58","author":"Schuurman","year":"2002","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1111\/j.1471-4159.2010.07123.x-BIB69|cit69","first-page":"S65","article-title":"Nonmotor manifestations of Parkinson\u2019s disease","volume":"64","author":"Simuni","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB70|cit70","first-page":"1","article-title":"Stress, protein (mis)folding, and signaling: the redox connection","volume":"239","author":"Sitia","year":"2004","journal-title":"Sci. STKE"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1089\/ars.2009.2490","article-title":"Protein misfolding and aggregation in Parkinson\u2019s disease","volume":"11","author":"Tan","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1471-4159.2007.04664.x","article-title":"Influence of human tryptophan hydroxylase 2\u2003N- and C-terminus on enzymatic activity and oligomerization","volume":"102","author":"Tenner","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/8192","article-title":"How the regulatory and catalytic domains get together","volume":"6","author":"Vrana","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clineuro.2009.02.005","article-title":"Validation of the Chinese non-motor symptoms scale for Parkinson\u2019s disease: results from a Chinese pilot study","volume":"111","author":"Wang","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0891-0618(92)90020-Q","article-title":"Immortalization of raphe neurons: an approach to neuronal function in vitro and in vivo","volume":"5","author":"White","year":"1992","journal-title":"J. Chem. Neuroanat."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","article-title":"The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases","volume":"27","author":"Winklhofer","year":"2008","journal-title":"EMBO J."},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.146.5.577","article-title":"Overview of depression and psychosis in Alzheimer\u2019s disease","volume":"146","author":"Wragg","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"10.1111\/j.1471-4159.2010.07123.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/ars.2009.2624","article-title":"Cell death pathways in Parkinson\u2019s disease: role of mitochondria","volume":"11","author":"Yao","year":"2009","journal-title":"Antioxid. Redox Signal."}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2010.07123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1471-4159.2010.07123.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T13:14:33Z","timestamp":1711977273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2010.07123.x"}},"subtitle":["TPH2 misfolding and 5HT deficits in PD"],"short-title":[],"issued":{"date-parts":[[2010,12,13]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07123.x","relation":{},"ISSN":["0022-3042"],"issn-type":[{"value":"0022-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,13]]}}}